Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
By MedImaging International staff writers Posted on 29 Apr 2024 |

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only accumulates in targeted tumor tissues but also disperses into surrounding healthy tissues, where it can remain for months to years, particularly in the brain and kidneys. The long-term impacts of this retention are still unclear, and gadolinium is known to cause several side effects. Consequently, the medical field has long been in search of a safer alternative. Now, an unexpected discovery made in a laboratory suggests that diamond dust, a carbon-based material, might serve as a viable, more tolerable substitute for gadolinium.
This breakthrough was achieved at the Max Planck Institute for Intelligent Systems (Stuttgart, Germany), where researchers initially used nanometer-sized diamond particles for an entirely different experimental purpose. To their surprise, these diamond particles exhibited unexpected brightness in an MRI experiment, shining even more brightly than the actual contrast agent, gadolinium. The experiment involved encapsulating 3 to 5-nanometer diamond particles in tiny drug-delivery capsules made of gelatin that were designed to burst upon heating, leveraging diamond dust's high heat capacity to trigger this reaction. Initially, the researchers included gadolinium to monitor the location of the diamond particles, intending to see if the diamond-enhanced capsules would heat more efficiently. However, they encountered issues with gadolinium leakage from the gelatin, similar to how it would leak out of the bloodstream into patient tissues during clinical use.
Upon deciding to proceed without gadolinium, they observed that the capsules still appeared surprisingly bright in the MRI images, indicating that the diamond dust could have better signal-enhancing properties than gadolinium. They found that, unlike gadolinium which diffuses everywhere, the diamond nanoparticles remained in the blood vessels, did not leak out, and later shone brightly in the MRI, similar to how they had in the gelatin capsules. Given these promising results, the researchers are optimistic about the potential of diamond dust in MRI applications. If further studies confirm its safety and efficacy, diamond dust could emerge as a groundbreaking contrast agent in future MRI procedures, offering a safer alternative to gadolinium.
“Why the diamond dust shines bright in our MRI still remains a mystery to us,” said Dr. Jelena Lazovic Zinnanti, a research scientist, who heads the Central Scientific Facility Medical Systems at MPI-IS. “I think the tiny particles have carbons that are slightly paramagnetic. The particles may have a defect in their crystal lattice, making them slightly magnetic. That’s why they behave like a T1 contrast agent such as gadolinium. Additionally, we don’t know whether diamond dust could potentially be toxic, something that needs to be carefully examined in the future.”
Related Links:
Max Planck Institute for Intelligent Systems
Latest MRI News
- AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more